O020 Asthma exacerbations and lung function decline in children during a 52-week controlled trial of omalizumab

Publication date: November 2016
Source:Annals of Allergy, Asthma & Immunology, Volume 117, Issue 5, Supplement
Author(s): B. Chipps, S. Szefler, K. Rosen, T. Haselkorn, B. Trzaskoma, B. Ortiz, B. Lanier, W. Busse




http://ift.tt/2fDotsA